Shell Asset Management Company »

Denali Therapeutics shares owned by Shell Asset Management Company

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Shell Asset Management Company from 13F filings

Historical chart of Shell Asset Management Company investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Shell Asset Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Shell Asset Management Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $22k 1.5k 14.75
2025-06-30 $56k 4.0k 13.97
2025-03-31 $61k 4.5k 13.69